To further investigate the prognostic value of CSC markers in ccRCC, we selected CD44 as a target because evidence indicated that CD44 was involved in tumor progression in ccRCC.33, 34 As shown in Figure 6f, we observed different intensities of immunostaining in tumor samples. This evidence concerns the gene CD44 and neoplasm.